Company Quick10K Filing
PHH
10-Q 2018-06-30 Filed 2018-08-03
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-03-01
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-06-30 Filed 2017-08-09
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-02-28
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-09
10-Q 2016-03-31 Filed 2016-05-05
10-K 2015-12-31 Filed 2016-02-26
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-06
10-Q 2015-03-31 Filed 2015-05-07
10-K 2014-12-31 Filed 2015-02-27
10-Q 2014-09-30 Filed 2014-11-05
10-Q 2014-06-30 Filed 2014-08-05
10-Q 2014-03-31 Filed 2014-05-08
10-K 2013-12-31 Filed 2014-02-26
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-01
10-Q 2013-03-31 Filed 2013-05-02
10-K 2012-12-31 Filed 2013-02-28
10-Q 2012-09-30 Filed 2012-11-08
10-Q 2012-06-30 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-02
10-K 2011-12-31 Filed 2012-02-28
10-Q 2011-09-30 Filed 2011-11-02
10-Q 2011-06-30 Filed 2011-07-29
10-Q 2011-03-31 Filed 2011-05-04
10-K 2010-12-31 Filed 2011-02-28
10-Q 2010-09-30 Filed 2010-11-03
10-Q 2010-06-30 Filed 2010-08-03
10-Q 2010-03-31 Filed 2010-04-30
10-K 2009-12-31 Filed 2010-03-01
8-K 2018-10-04
8-K 2018-10-01
8-K 2018-09-28
8-K 2018-08-03
8-K 2018-06-11
8-K 2018-06-01
8-K 2018-05-24
8-K 2018-05-09
8-K 2018-05-08
8-K 2018-04-26
8-K 2018-02-27
8-K 2018-02-27
8-K 2018-01-25
8-K 2017-12-31

PHH Financials

PHH Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Farmers Capital Bank (FFKT) 403 8.9 0% 10,900 1,434 0 0 16 35 310
Keryx Biopharmaceuticals (KERX) 402 0% -4.1 -60% 152 206 94 0 -91 -91 376
TCR2 Therapeutics (TCRR) 399 -10.2 -19% 180 8 0 0 -35 -34 350
Hennessy Capital Acquisition III (HCAC) 381 0% -35.1 -18% 422 475 432 0 -75 -21 747
Charter Financial (CHFN) 381 7.4 1% 1,626 1,401 0 0 17 36 265
Invesco DB Agriculture Fund (DBA) 381 -13.2 -7% 384 0 0 0 -29 -29 381
Karuna Therapeutics (KRTX) 380 -9.0 -15% 164 2 0 0 -24 -24 218
Semler Scientific (SMLR) 365 88% 43.9 65% 19 5 24 21 12 8 357
Gulfmark Offshore (GLF) 354 0% 26.1 -6% 417 135 79 0 -27 16 417
PHH (PHH) 354 0% -0.2 -10% 1,442 953 315 0 -138 -149 37
Harpoon Therapeutics (HARP) 350 0% -5.8 -29% 142 35 5 0 -41 -40 229
Government Properties Income Trust (GOV) 349 0% 1.1 -1% 4,360 2,694 343 0 -35 298 316
JEM Capital (JEM) 346 -17,698.3 0 0 0 0 -0 -0 346
Fellazo (FLLZ) 345 -1,969.0 -849% 0 1 0 0 -0 -0 345
Castle Biosciences (CSTL) 335 85% 35.2 4% 113 31 26 22 5 8 265
New York & Company (NWY) 330 29% -12.5 -4% 486 430 850 249 -21 -21 265
Invesco DB US Dollar Index Bullish Fund (UUP) 330 16.0 6% 331 0 0 0 21 21 330
Zynex (ZYXI) 324 62% 25.1 37% 25 8 41 25 9 12 312
Atreca (BCEL) 311 -4.3 -16% 213 8 0 0 -34 -33 143
Corium (CORI) 306 0% -4.9 -50% 112 87 38 0 -57 -45 224

Balance Sheet ($MM)2010-09-302010-12-312011-03-312011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-30
Cash2591953252914148757006778299271,0441,1551,2451,1559641,4511,2591,2699589829069371,0059969069361,001494542536495
Accounts Receivable5515736067297006936637427977429729399811,000637672123126103888172828966617494785658
Inventory
PP&E444645592446365682817976733086942382073541461965250501973228241491918
Assets9,46211,2708,5589,3359,7779,2469,3879,2469,6039,2569,7719,0998,8488,5428,9384,6834,2964,3384,4943,8653,6523,4503,6313,4463,1752,8512,9062,3011,8111,5131,442
Accounts Payable
Long-Term Debt6,5798,0855,3956,6096,9606,3156,4926,4046,6326,2786,3855,8625,5515,3742,2041,6131,7681,8101,9121,3901,3581,3191,4801,3401,2701,0901,199654371165178
Liabilities8,0579,6926,9217,8938,3167,6777,8627,7478,0417,6488,0847,4567,1586,8987,3383,0752,7252,7392,9672,3862,3042,1542,3502,1862,0521,8001,9281,6631,258990953
Stockholders' Equity1,3761,5641,6251,4271,4421,5541,4951,4631,5261,5751,6621,6181,6661,6221,5741,5791,5451,5711,4971,4471,3181,2661,2481,2241,0921,024955594553523489
Income Statement ($MM)2010-09-302010-12-312011-03-312011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-30
Revenue572918665384649777559624783730822615675517196152180261237169123157196197721141121211095035
Cost of Revenue
Gross Profit
R&D
SG&A
Tax-912633-104039-38-33263256-2817-27-12-44-108-18-40-32-19-11-8-73-34-33-362401
Net Income718152-1382185-42-237364189-4644-44-55218-3223-56-47-51-30-9-21-133-71-50-42-31-30-35
Cash Flow ($MM)2010-09-302010-12-312011-03-312011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-30
Cash Operating-1,2313,1544471,44368291-1,687833416802-2,057471129-666-119-3305086221-15715653192-142-53306163-55
Cash Investing-292-308-432-321-411-172915-379-392-137-269-39586833087-4643-227465-22-6718211015752
Cash Financing1,460-2,714316-661167-141836-35696-5561,042-162-7841444265-527-116-64160-143-76-180186-555-315-21512